Watching Neogen; Traders Circulate Unconfirmed Analyst Report Defending NEOG After Sell-Off, Says Product Is Third-Party Manufactured, Revenue Impact Immaterial And FDA Dialogue Ongoing

Loading news article.

Watching Neogen; Traders Circulate Unconfirmed Analyst Report Defending NEOG After Sell-Off, Says Product Is Third-Party Manufactured, Revenue Impact Immaterial And FDA Dialogue Ongoing | WAPE

Watching Neogen; Traders Circulate Unconfirmed Analyst Report Defending NEOG After Sell-Off, Says Product Is Third-Party Manufactured, Revenue Impact Immaterial And FDA Dialogue Ongoing

Article summary

Related companies

Comments —